# Adversarial Position Review: LULU (Lululemon Athletica)

> **Date:** 2026-02-11
> **Type:** Adversarial review of existing position
> **Entry:** $171.62 on 2026-02-05
> **Current Price:** $178.90 (EUR 150.38)
> **Holding Period:** 6 days
> **Unrealized P&L:** +4.2% ($14.56 gain on 2 shares)
> **Reviewer Framework:** v4.0 Principled Reasoning

---

## 1. QS Tool vs Thesis

### Quality Scorer Tool Output

| Category | Tool Score | Thesis Claim | Delta |
|----------|-----------|--------------|-------|
| **Financial Quality** | 35/40 | 34/40 | +1 |
| **Growth Quality** | 25/25 | 23/25 | +2 |
| **Moat Evidence** | 17/25 | 22/25 | **-5** |
| **Capital Allocation** | 3/10 | 3/10 | 0 |
| **TOTAL** | **80/100** | **82/100** | **-2** |
| **Tier** | **A** | **A** | Same |

### Analysis of QS Discrepancy

The thesis claimed 82, the tool produces 80. The gap is small (-2 points) and within acceptable range (<5 points, per QS Tool-First rule). The main discrepancy is in **Moat Evidence**:

- **Tool gives 17/25**: Market Position scores 0/8 because the tool defaults to 0 for market position (requires manual input). This is a known tool bias documented in Session 53 (`quality_scorer.py` `market_position` default issue).
- **Thesis claimed 22/25**: Added +5 for market position (#2 in US athleisure, 21% DTC share) which is defensible.

**QS Adjusted: 80 + 5 (market position #2) = 85/100 Tier A**

However, applying adversarial adjustments:
- **Market share DECLINING**: DTC share from 30% to 24% (Jan-Nov 2025). This is not a stable #2 position -- it is eroding. Market position should be 5/8, not 8/8.
- **Moat under active competitive pressure**: Alo Yoga surged from 8% to 14% DTC share in just 3 months (Sep-Nov 2025). Vuori stable at 5% but expanding to 100 stores.
- **Product quality issues**: "Get Low" leggings pulled for see-through fabric (Jan 2026). Second such incident after Breezethrough summer 2025. This is not consistent with a brand commanding +23pp gross margin premium.

**QS Adversarial Adjusted: 80 + 3 (market position eroding) - 2 (moat under siege, product quality) = 81/100 Tier A**

**Verdict: Tool QS 80, Thesis QS 82, Adversarial QS 81. All Tier A. The thesis QS was slightly inflated but not materially so.** The tier is correctly identified. This is NOT the same pattern as NVO/AUTO.L/BYIT.L where QS was inflated by 10-14 points.

---

## 2. What Has Changed Since Thesis (Feb 5, 2026)

### Positive Developments

1. **ICR Conference Q4 Update (Jan 12, 2026):** Management raised Q4 guidance to high end of revenue ($3.585B) and EPS ($4.76). Holiday season was strong. This is incrementally positive.

2. **Elliott Management $1B Stake (Dec 2025):** Activist investor with track record of value creation. Pushing for Jane Nielsen (ex-Ralph Lauren CFO/COO) as CEO. This adds urgency to the CEO search and creates accountability.

3. **New Product Launch -- "Unrestricted Power" (Feb 10, 2026):** New strength training line launched. Demonstrates continued innovation pipeline.

4. **International Expansion Commitment:** 6 new markets in 2026 (Greece, Austria, India, etc.) -- largest single-year expansion ever. Pipeline of international growth visible.

5. **Stock Price +4.2%:** From $171.62 to $178.90 since entry. Modest positive move.

### Negative Developments

1. **"Get Low" Product Pull (Jan 20, 2026):** See-through fabric complaints led to product pull. This is the SECOND quality control failure in 6 months (after Breezethrough). Bloomberg called it a "scandal deepening investor activism." The company's response -- blaming customers for sizing -- was criticized. This is concerning for a brand built on product quality premium.

2. **DTC Market Share Erosion Accelerating:** DTC share dropped from 30% (Jan 2025) to 24% (Nov 2025) -- a 6 percentage point loss in 10 months. Alo Yoga surged from 8% to 14%. This was WORSE than the thesis assumed. Thesis said "Alo 14% DTC, LULU 24% DTC" as a snapshot -- but the TRAJECTORY is the problem. If Alo continues +2pp/quarter...

3. **FY2026 Tariff Impact Quantified: $320M:** Management estimates $320M net impact on operating income in FY2026 from tariffs and de minimis elimination. With ~$10.5B revenue, this is approximately 300bp of operating margin compression. The thesis said "~100bp GM impact, marginal" -- that was WRONG. $320M on ~$2.5B operating income is ~13% hit.

4. **Operating Margin Guidance: -390bp for FY2025:** Full-year operating margin guided down ~390bp vs FY2024. Thesis assumed operating margin at 24-25% normalized -- but actual trajectory is downward.

5. **FY2025 EPS Guidance: $12.92-$13.02 vs FY2024 $14.64:** This is an EPS DECLINE of -11% year-over-year. The thesis assumed 8-10% revenue growth -- but EPS is going backwards.

6. **Chip Wilson Proxy Fight Escalating:** Wilson nominating 3 board directors, annual meeting June 2026. Wilson and Elliott are NOT coordinating ("no substantive contact"). Two activists with potentially conflicting priorities creates governance risk and management distraction.

7. **Multiple "Strategic Update" Calls Expected (Feb-Mar):** The interim co-CEO structure is being pressured to address Elliott's demands. This creates uncertainty and potential for negative surprises.

### Net Assessment of Changes

The thesis was written with optimistic assumptions about tariff impact, product refresh success, and competitive dynamics. Since Feb 5:
- Tariff impact is 3x worse than assumed ($320M vs thesis "~100bp marginal")
- Product refresh has a VISIBLE failure (Get Low) adding to brand risk
- Market share erosion data is worse than the snapshot in thesis
- EPS is declining, not growing
- Governance is more complex (two uncoordinated activists + interim co-CEOs)

**These changes WEAKEN the thesis but do not invalidate it.** The core strengths (ROIC 47%, GM 59%, FCF positive, net cash, international growth) remain intact.

---

## 3. Thesis Assumptions Stress-Test

### Assumption 1: "US weakness is CYCLICAL, not structural"

**Thesis Claim:** Product stale, cyclical downturn. Spring 2026 product refresh (35% newness) will fix it.

**Adversarial Challenge:**
- US comparable sales have been negative for 4+ consecutive quarters (Q2-Q3 FY2025 negative, Q4 FY2025 guided at -3% to -1%)
- DTC market share fell 6pp in 10 months (30% to 24%) -- this is ACCELERATING share loss
- Two product quality failures in 6 months (Breezethrough summer 2025, Get Low Jan 2026)
- CEO departed, no permanent replacement, two activists at the door
- Alo Yoga growing 88% YoY at peak, Vuori opening 100 stores

**Counter-argument (supporting cyclical thesis):**
- Gross margin 59.2% is AT ALL-TIME HIGH -- if the moat were structurally impaired, GM would be eroding
- International growth (+33%, China +46%) proves the BRAND is strong -- the problem is US execution
- Product quality issues (Get Low) are embarrassing but recoverable -- Nike had worse (Vaporfly disintegration) and recovered
- Alo/Vuori are growing from tiny base -- 14% and 5% DTC share respectively, total 19% vs LULU 24%. LULU is still larger than both combined
- The "accelerating share loss" could also be a measurement artifact -- holiday DTC data is volatile

**Verdict:** **60% cyclical, 40% risk of structural.** The thesis assumes 100% cyclical -- this was overconfident. The share loss trajectory and repeated product quality issues introduce meaningful structural risk. I am adjusting from "100% cyclical" to "60/40 cyclical/structural" which means some permanent share loss should be baked into projections.

### Assumption 2: "China +46% growth is sustainable"

**Thesis Claim:** International compensates US. China +46%, Rest of World +20%.

**Adversarial Challenge:**
- China PMI data is WEAK: services PMI 49.4 (37-month low), official manufacturing 49.3 (contraction)
- China Q1 2025 growth already moderated to +22% from +46% in Q3 2025
- Chinese athleisure brands (Anta, Li-Ning, Maia Active) are expanding in their home market at lower price points
- World view says "Evitar China. Riesgo politico alto" -- yet LULU has 15% revenue exposure
- LULU's China store expansion requires capital in a market with structural demand challenges

**Counter-argument:**
- LULU's China addressable market is "affluent urban consumer" -- different from the mass market PMI data reflects
- Even at moderated 20-25% growth, China contributes meaningfully to company-wide growth
- LULU has only ~150 stores in China vs management's long-term potential of 500+ -- early innings

**Verdict:** **China growth is real but decelerating.** The thesis used Q3's +46% as a run-rate proxy. More realistic forward assumption: 20-25% for FY2026, moderating to 15-20% by FY2028. This reduces overall revenue growth by ~2-3pp vs thesis assumptions.

### Assumption 3: "Product refresh Spring 2026 is the catalyst"

**Thesis Claim:** 35% newness in Spring 2026 will drive US recovery.

**Adversarial Challenge:**
- "Unrestricted Power" launched Feb 10, 2026 -- too early to measure sell-through
- "Get Low" launch was a FAILURE -- pulled for quality issues in Jan 2026
- Lunar New Year collections launched -- aesthetically driven, not indicative of core innovation
- The thesis assumes "product refresh" as a SINGLE catalyst, but retail product cycles take 2-3 quarters to impact comps
- No permanent CEO to champion the refresh -- interim co-CEOs managing day-to-day

**Counter-argument:**
- One product failure out of many launches is not unusual for apparel companies
- The 35% newness figure is a pipeline metric, not a single product bet
- Spring collection is just arriving -- judging it by Jan data is premature

**Verdict:** **Catalyst is plausible but unverifiable today.** We will not know until Q1 FY2026 earnings (June 2026). The Get Low incident raises quality control concerns that were not in the original thesis.

### Assumption 4: "CEO transition is orderly and manageable"

**Thesis Claim:** McDonald stays as advisor until March. Co-CEOs (CFO + CCO) are experienced. Board conducting search.

**Adversarial Challenge:**
- Elliott has $1B stake and a specific CEO candidate (Jane Nielsen from Ralph Lauren)
- Chip Wilson is running a proxy fight, nominating 3 board directors for June 2026 annual meeting
- Wilson and Elliott are NOT coordinating -- "no substantive contact" per Semafor
- Two uncoordinated activist investors with potentially conflicting priorities = maximum governance chaos
- Interim co-CEO structure is "rarely viewed favorably by Wall Street"
- Bloomberg characterized it as deepening into a "scandal" (in context of Get Low)
- Strategic update calls expected Feb-Mar where interim team must address Elliott demands

**Counter-argument:**
- Elliott's involvement is actually POSITIVE -- they have a track record of creating value
- Jane Nielsen from Ralph Lauren would be an excellent CEO choice (retail experience, operational rigor)
- Wilson's proxy fight creates accountability for the board
- The interim team (Meghan Frank, Andre Maestrini) are respected internally

**Verdict:** **CEO situation is MORE COMPLEX than thesis assumed.** The thesis said "manageable" -- but TWO uncoordinated activists + interim management + proxy fight + product quality issues is a level of governance complexity that creates real uncertainty. This is not a clean "board searches, new CEO arrives, business continues" story. The risk here is that management time and energy goes to fighting activist battles rather than executing the product refresh.

### Assumption 5: "Tariff impact is marginal (~100bp GM)"

**Thesis Claim:** Supply chain diversifying, pricing power absorbs.

**Adversarial Challenge:**
- Management now quantifies tariff impact at $320M net for FY2026 -- this is ~13% of operating income
- Tariffs hit all major sourcing countries: China 54%, Vietnam (1/3 of production) affected, Cambodia 49%, Sri Lanka 44%, Indonesia 32%
- De minimis elimination adds additional friction
- FY2025 operating margin guided DOWN 390bp
- Even AFTER mitigation, the hit is massive compared to thesis assumption of "marginal"

**Counter-argument:**
- The $320M figure includes current tariffs that may be renegotiated or reduced
- LULU has pricing power -- selective price increases can offset some impact
- Supply chain diversification (to India, Bangladesh) is underway
- Tariff impact is industry-wide -- it is not a LULU-specific competitive disadvantage

**Verdict:** **Tariff impact is MATERIAL, not marginal.** The thesis was wrong on this. $320M is 3-4x what was assumed. This does not kill the thesis (it affects the entire sector) but it materially reduces near-term earning power and must be reflected in valuation.

### Assumption 6: "Competitive moat is intact (GM 59% proves it)"

**Thesis Claim:** GM +23pp vs sector proves moat intact. Alo/Vuori gaining from small base.

**Adversarial Challenge:**
- GM being high does NOT prove moat is intact -- it proves the moat WAS intact. The question is the trajectory.
- DTC share loss of 6pp in 10 months is a leading indicator -- GM compression is a lagging indicator
- Alo Yoga's growth rate (88% peak, 8% to 14% share in 3 months) is extraordinary
- Two product quality failures in 6 months damage the "premium quality = premium price" value proposition
- Customer overlap: 63% Alo/LULU, 52% Vuori/LULU -- these are the SAME customers choosing alternatives

**Counter-argument:**
- Gross margin actually EXPANDED in 2025 (from 58.3% to 59.2%)
- ROIC 47% is at near-record highs
- If moat were truly eroding, GM would be the first signal, and it is not
- Alo's growth is from a tiny $500M revenue base vs LULU $10.6B -- scale matters

**Verdict:** **Moat is intact TODAY but showing cracks.** The GM data supports the thesis, but the DTC share loss and product quality issues are early warning signs. I would not call this structural moat erosion yet, but I would increase the monitoring frequency.

---

## 4. Revised Fair Value

### Issue with Original Valuation

The thesis used:
1. DCF Base Case $241 (60% weight) -- assumed 8-10% revenue growth
2. P/E 20x method $290 (40% weight) -- half of historical average
3. Weighted FV: $261

**Problems identified:**
- Revenue growth was assumed at 8-10%, but FY2025 EPS is DECLINING (-11% YoY)
- Operating margin was assumed recovering to 24-25%, but is actually declining 390bp
- Tariff impact was assumed "marginal" but is $320M
- P/E 20x was calibrated vs historical 40x, but historical included hyper-growth that is NOT returning in the near term
- The $320M tariff drag means FY2026 operating income will be compressed by ~13%

### DCF Sensitivity Analysis (Tool Results)

| Scenario | Growth | WACC | Terminal | FV/Share | MoS vs $179 |
|----------|--------|------|----------|----------|-------------|
| **Conservative (3%)** | 3% | 10.5% | 2.0% | $170.14 | **-5.1%** |
| Conservative Bear | 1% | 11.5% | 2.0% | $138.91 | **-22.5%** |
| **Moderate (5%)** | 5% | 10.0% | 2.5% | $207.90 | **+16.0%** |
| Moderate Bear | 3% | 11.0% | 2.5% | $167.32 | **-6.7%** |
| **Thesis (8%)** | 8% | 10.0% | 2.5% | $236.32 | **+31.8%** |
| Thesis Bull | 10% | 9.0% | 2.5% | $299.03 | **+66.8%** |

### What Growth Rate is Justified?

- **Historical FCF CAGR (4yr):** +19.2% revenue, +25% EPS (but this includes post-COVID bounce)
- **FY2025 reality:** Revenue +5-7% ex-53rd week, EPS -11%
- **FY2026 management guidance:** Revenue +2-4% ($10.85-$11B), tariff headwind $320M
- **Consensus FY2026 EPS:** ~$12.92-$13.02 (DOWN from $14.64)

The thesis assumed 8-10% growth. Reality is:
- FY2025: +5-7% revenue, EPS declining
- FY2026: +2-4% revenue, tariff headwind $320M

**Forward growth rate adjustment:** Given tariff headwind, US weakness, decelerating China growth, and management guidance, a 5% revenue growth rate is more realistic for the next 3-5 years (US recovery + international growth - tariff drag). This is below the thesis's 8-10% but above the current 2-4% guided (which includes maximum tariff impact that may moderate).

### P/E Method Recalibration

- EPS FY2025e: ~$12.97 (midpoint of guidance $12.92-$13.02)
- EPS FY2026e: ~$12.50 (consensus estimate reflecting tariff impact)
- P/E 20x was the thesis assumption. But with EPS declining and growth at 2-5%, 20x is GENEROUS.

Comparable companies:
- Nike (NKE): P/E 37x but negative earnings growth
- Deckers (DECK): P/E 16x with 24% growth
- Gap (GAP): P/E 13x with modest growth
- Ross Stores (ROST): P/E 23x as quality retailer benchmark

For a company with 2-5% near-term growth, mid-teens is more appropriate. Using 16-18x on normalized EPS:
- FV @ 16x * $12.50 = $200
- FV @ 18x * $12.50 = $225

### Revised FV Calculation

| Method | Fair Value | Weight | Weighted |
|--------|-----------|--------|----------|
| DCF (5% growth, 10% WACC) | $208 | 50% | $104 |
| P/E (17x * $12.50) | $213 | 30% | $64 |
| Bear Floor (3% growth, 10.5%) | $170 | 20% | $34 |
| **Weighted FV** | | 100% | **$202** |

### Comparison

| Metric | Original Thesis | Adversarial Review | Delta |
|--------|----------------|-------------------|-------|
| FV | $261 | **$202** | **-22.6%** |
| MoS at entry ($172) | 34% | 15% | **-19pp** |
| MoS at current ($179) | 31% | 11% | **-20pp** |
| Growth assumption | 8-10% | 5% | -3-5pp |
| P/E multiple | 20x | 17x | -3x |
| Tariff impact | "marginal" | $320M (13% of OpInc) | Material |

---

## 5. Kill Conditions Check

| Kill Condition | Status | Assessment |
|----------------|--------|------------|
| GM <50% | **OK** (59.2%) | Healthy, expanding |
| 3Q negative global comps | **APPROACHING** | US negative 4+ quarters. Global STILL positive thanks to international, but if FY2026 guidance of +2-4% reflects slowing international... |
| FCF negative 2Q | **OK** | FCF $1.6B, positive 4/4 years |
| Bad CEO appointment | **PENDING** | No CEO yet. Elliott pushing Jane Nielsen (strong candidate). Wilson pushing board changes. Uncertainty HIGH. |
| Chip Wilson board disruption | **ELEVATED** | Proxy fight active, 3 director nominees, June 2026 vote |
| DTC channel commoditized | **OK** | Not triggered, but Alo/Vuori share gains are worth monitoring |
| Chinese brands quality parity | **OK** | Not triggered yet |

**Overall Kill Conditions: None TRIGGERED, one APPROACHING (global comps), one ELEVATED (Wilson proxy fight).**

---

## 6. Value Trap Checklist (Adversarial)

| Factor | Assessment | Comment |
|--------|-----------|---------|
| Industria en declive secular | NO | Athleisure growing 7-9% CAGR |
| Disrupcion tecnologica | NO | No tech disruption in apparel |
| Management destruyendo valor | PARTIAL | No permanent CEO, two activists, product quality issues |
| Balance deteriorandose | NO | Net debt 0.2x, net cash essentially |
| Insider selling masivo | NO | Wilson buying/nominating, Elliott bought $1B |
| Dividend cut probable | N/A | No dividend |
| Perdida market share >2pp 3yr | **YES** | DTC share from 30% to 24% in 10 months |
| ROIC < WACC | NO | ROIC 47% >> WACC 9.6% (+37pp spread) |
| FCF negativo >2 anos | NO | FCF $1.6B positive |
| Goodwill >50% equity | NO | Clean balance sheet |

**Result: 1.5/10** (market share loss confirmed, management quality partially concerning)

---

## 7. Verdict

### HOLD -- LOW-MEDIUM Conviction

**Reasoning from Principles:**

**Principle 5 (QS as Input):** QS 80-81 Tier A. The quality metrics are genuinely strong -- ROIC 47% with +37pp spread, GM 59% expanding, FCF $1.6B, net cash. These are not the metrics of a value trap. The adversarial review confirms this is a quality business facing cyclical headwinds, not a deteriorating one.

**Principle 6 (Selling Requires Argument):** Is there a clear argument to SELL?
- The thesis is WEAKENED but not invalidated
- MoS has compressed from 34% (thesis) to ~11% (adversarial at current price)
- But MoS is still POSITIVE -- we are not overpaying
- No kill condition is triggered
- Position is small (3.5% of portfolio, $343 invested)
- P&L is positive (+4.2%)

**Principle 7 (Consistency with Precedents):** In the adversarial review of 13 positions, I sold when:
- MoS turned negative (SAN.PA, SHEL.L, PFE) -- LULU MoS is still +11%
- ROIC < WACC (TEP.PA, LIGHT.AS, A2A.MI, VNA.DE) -- LULU ROIC is +37pp over WACC
- FV was inflated >20% AND fundamental deterioration (HRB) -- LULU FV is revised -23% but fundamentals (GM, ROIC, FCF) remain strong

LULU does NOT match the profile of the 8 positions I sold. The FV was inflated (like 12/13 others), but the underlying business quality is genuinely strong.

**Principle 9 (Quality Gravitation):** LULU at QS 80-81 IS a Tier A quality compounder. This is the kind of business we WANT in the portfolio. The question is not "is this a quality business" (yes) but "is the price right" (MoS +11% is thin but positive).

**Why not SELL:**
1. ROIC 47% with +37pp spread -- this is one of the highest ROIC spreads in the portfolio
2. Gross margin EXPANDING (59.2%, all-time high) -- not the profile of a dying brand
3. FCF $1.6B, net cash -- fortress balance sheet
4. International growth real (+33%, China moderating but still 20%+)
5. Elliott $1B stake is a positive catalyst (activist with value creation track record)
6. Position is small (3.5%) -- downside impact is limited
7. Entry was recent (6 days ago) -- insufficient time to evaluate thesis catalysts

**Why not ADD:**
1. MoS compressed to ~11% (from 34%) -- not attractive enough to increase position
2. Multiple headwinds: tariffs ($320M), CEO uncertainty, proxy fight, product quality issues
3. FY2025 EPS declining -11% -- need to see stabilization before adding
4. Q4 FY2025 results (Mar 31) will be important for validating recovery
5. Conviction reduced from HIGH to MEDIUM due to tariff reality and governance complexity

**What Would Change My Mind:**
- SELL trigger: GM below 55% (approaching kill condition), negative global comps 2+ quarters, or CEO appointment that is clearly wrong (no retail experience, Wilson-controlled board)
- ADD trigger: Price below $160 (MoS >26% on adversarial FV) AND Q4 shows US comp improvement
- UPGRADE conviction: Strong Q4 results + credible CEO appointment + tariff moderation

### Summary

| Metric | Value |
|--------|-------|
| **QS Tool** | 80/100 Tier A |
| **QS Adjusted** | 81/100 Tier A |
| **Thesis FV** | $261 |
| **Adversarial FV** | **$202** (-22.6%) |
| **Current Price** | $178.90 |
| **MoS (Adversarial)** | **+11.4%** |
| **Status** | **HOLD -- Low-Medium Conviction** |
| **Kill Conditions** | None triggered, 1 approaching, 1 elevated |
| **Position Size** | 3.5% (~$343 invested) -- appropriate, no change |

### Standing Orders Update

- **CANCEL previous ADD triggers** ($160, $145): These were based on thesis FV of $261. At adversarial FV $202, the ADD levels should be:
  - New ADD trigger: $155 (MoS >30% on adversarial FV), conditional on Q4 FY2025 comp improvement AND CEO clarity
- **No SELL order needed**: MoS is positive, no kill conditions triggered

### Next Review Triggers

1. **Q4 FY2025 earnings (Mar 31, 2026):** Critical -- US comps, international growth, FY2026 detailed guidance
2. **CEO announcement:** Could be catalyst (+/-)
3. **Annual meeting (June 2026):** Wilson proxy vote result
4. **Any kill condition approaching:** Monitor GM quarterly

---

## META-REFLECTION

### Changes Detected Since Last Review
- Tariff impact is 3-4x what thesis assumed ($320M vs "marginal ~100bp")
- DTC market share erosion is accelerating (6pp in 10 months)
- Product quality failures (Get Low) were not anticipated
- Governance complexity increased significantly (two activists, interim management, proxy fight)
- EPS is DECLINING (-11% YoY), not growing as thesis assumed
- FV revised down 22.6% ($261 to $202) -- consistent with adversarial pattern (12/13 positions had inflated FV, avg -15%)

### Incertidumbres
- Q4 FY2025 results not yet reported (Mar 31) -- US comp trend is critical
- CEO search outcome unknown -- could be highly positive (Jane Nielsen) or negative
- Tariff landscape could change with trade negotiations -- $320M may be peak impact or could worsen
- Spring 2026 product refresh sell-through data not available yet
- China growth moderation rate is uncertain (was 46%, moderated to 22%, could moderate further)

### Sugerencias
- **Update standing orders in system.yaml** to reflect adversarial FV
- **Monitor Q4 earnings closely** (Mar 31) -- this is the most important near-term event
- **Track Alo Yoga DTC share monthly** -- if it crosses 18%+ while LULU drops below 20%, moat thesis weakens significantly
- **Consider whether LULU's presence in portfolio is best use of capital** if better Tier A alternatives emerge with higher MoS

### Alertas para Orchestrator
- The thesis FV inflation (-22.6%) is consistent with the adversarial pattern across the portfolio
- However, LULU is genuinely Tier A quality (unlike many of the 8 positions sold) -- the business fundamentals are strong
- The position is small enough (3.5%) that even in a worst case, impact is manageable
- PRIORITY: Monitor Q4 earnings (Mar 31) and CEO appointment -- these two events will determine whether conviction upgrades or position is exited

---

## Sources

### Q4 Update & Earnings
- [Lululemon ICR Conference Q4 Update](https://corporate.lululemon.com/media/press-releases/2026/01-12-2026-113012292)
- [Lululemon Q4 Earnings & Revenue Beat](https://finance.yahoo.com/news/lululemon-q4-earnings-revenues-beat-124000417.html)
- [TipRanks: LULU Earnings](https://www.tipranks.com/stocks/lulu/earnings)

### CEO Search & Activism
- [Elliott Takes $1B Stake in Lululemon](https://www.businessoffashion.com/news/sports/activist-investor-takes-over-1-billion-stake-in-lululemon/)
- [Chip Wilson Proxy Fight](https://chainstoreage.com/lululemon-founder-launches-proxy-fight-overhaul-board)
- [Yahoo Finance: Proxy Fight at Lululemon](https://finance.yahoo.com/news/proxy-fight-just-broke-lululemon-163557758.html)
- [SGB: Lululemon Responds to Proxy Battle](https://sgbonline.com/lululemon-responds-to-founders-proxy-battle/)

### Competition & Market Share
- [Retail Dive: Alo Yoga, Vuori Gaining Share](https://www.retaildive.com/news/alo-yoga-vuori-gaining-activewear-market-share/714384/)
- [CNBC: How Vuori Reached $5.5B Valuation](https://www.cnbc.com/2024/12/19/how-vuori-is-taking-on-lululemon.html)
- [Retail TouchPoints: Athleisure Faceoff](https://www.retailtouchpoints.com/topics/market-news/athleisure-faceoff-how-lululemon-vuori-alo-and-fabletics-are-making-their-case-to-consumers)

### Tariff Impact
- [Supply Chain Dive: De Minimis Impact on Lululemon](https://www.supplychaindive.com/news/lululemon-de-minimis-elimination-impact-2025/760670/)
- [Globe and Mail: LULU Tariff Strategy Backfires](https://www.theglobeandmail.com/investing/markets/stocks/UAA/pressreleases/31727179/lululemon-stock-lulu-hammered-as-tariff-strategy-backfires/)
- [Supply Chain Magazine: Tariffs and Declining Sales](https://supplychaindigital.com/news/lululemon-tariffs-sales-impact)

### Product Issues
- [CBS: Lululemon Pulls Get Low Leggings](https://www.cbsnews.com/news/lululemon-see-through-leggings-get-low/)
- [Bloomberg: See-Through Leggings Scandal Deepens Activism](https://www.bloomberg.com/news/features/2026-01-29/lululemon-s-see-through-leggings-scandal-deepens-investor-activism)
- [Retail Dive: Get Low Leggings Back Online With Caveats](https://www.retaildive.com/news/lululemon-get-low-leggings-back-online-see-through-skin-tone-underwear/810359/)

### International Expansion
- [Lululemon to Enter Six New Markets in 2026](https://corporate.lululemon.com/media/press-releases/2025/12-18-2025-113011673)
- [Lululemon: Unrestricted Power Launch](https://corporate.lululemon.com/media/press-releases/2026/02-10-2026-133015993)

### Analyst Consensus
- [MarketBeat: LULU Forecast](https://www.marketbeat.com/stocks/NASDAQ/LULU/forecast/)
- [Public.com: LULU Analyst Ratings](https://public.com/stocks/lulu/forecast-price-target)
- [Stock Analysis: LULU Forecast](https://stockanalysis.com/stocks/lulu/forecast/)
